Jon has developed software to help drug developers predict the effects of new drugs on auto-immune diseases, such as rheumatoid arthritis and multiple sclerosis.
His software is capable of integrating far more data and concepts than the systems currently used by drug developers creating clinical trials of new products. The increased data input through Jon's system results in improved confidence in computer simulations, cost savings and quicker speed to market for new drug releases.
Jon is Professor of Intelligent and Adaptive Systems at the University of York, where his research focuses on building computer models of immune function in the human body. He is the founder of SimOmics, a spin out of the University of York, which is expanding on these developments.
